Kenneth J. Bock
Senior Advisor @Kadenwood Group
Signup · Get unlimited contacts
WORK HISTORY
Senior Advisor @Kadenwood Group
Kadenwood Group is an independent boutique investment bank delivering senior-led execution with advisors who have collectively executed $1T+ in transactions. The advisory bench averages 30+ years at top institutions (e.g, Moelis, Morgan Stanley, Guggenheim, JP Morgan, Credit Suisse, PwC) brings bulge-bracket judgment without bureaucracy. Differentiated capital access via an industry-leading family office platform: 850+ relationships working as a direct bridge to flexible, patient capital.
EDUCATION
New York University
BS, Economics
NYU Stern School of Business
MBA, Finance
ABOUT KENNETH J. BOCK
Board Representation/ Growth Strategies / Business Development / Strategic Alliances & Joint Ventures / ROI Improvement Global Capital Markets / Structured Investments / P&L / Startups / Turnarounds / Team Building / IRKnown for visionary strategic thinking, natural leadership and fostering a high-performance, collaborative corporate culture. Credentials include MBA in Finance from NYU Stern School of Business and BS in Economics from NYU.Significant accomplishments include:Strategic Planning and Implementation: Hired by Morgan Stanley to increase their business lines. Prepared the business plans and budgets for five business lines. All were approved by the Management Committee. I was a member of the implementation team before moving to the next project. Named Treasurer of the company’s global derivatives business.Turned Around Failing Subsidiaries: Recruited as special advisor to the Board of Munich Reinsurance in 2002 to assess the viability of two similar subsidiaries. Recommended both a run-off and a turnaround strategy. The latter was approved, and I was appointed CEO and board member. Reorganized, rightsized and rebranded the entities. Established policies and procedures and led the company from millions in losses to breakeven in 18 months.Created Groundbreaking Funding Platforms: Devised a structured global investment solution and was involved in closing deals worth more than $1.25B. The structure is a primary funding source in life insurance industry.Independent Board Member for a Publicly Traded Company: Dialysis Corporation of America, I played key internal advisory role in the the successful $112 million tender offer from US Renal Care in 2010.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.